Quick Answer
LIPELLA PHARMACEUTICALS INC. reported Stockholders Equity of $1.92 million for the year ending 2024.
- LIPELLA PHARMACEUTICALS INC. showed a decrease of -39.0% in Stockholders Equity from 2023 to 2024.
- This data is from LIPELLA PHARMACEUTICALS INC.'s annual report (Form 10-K), filed with the SEC on March 28, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: $920.8 thousand | Q2 2022: $352.2 thousand | Q3 2022: -$62.8 thousand | Q1 2023: $3.82 million | Q2 2023: $3.13 million | Q3 2023: $2.22 million | Q4 2023: $3.14 million | Q1 2024: $2.56 million | Q2 2024: $1.70 million | Q3 2024: $1.46 million | Q4 2024: $1.92 million | Q1 2025: $4.08 million | Q2 2025: $2.74 million | Q3 2025: $1.49 million.
- Over the full 5 years of available data (2020 to 2024), LIPELLA PHARMACEUTICALS INC.'s Stockholders Equity has grown by 314.3%.
- Historical annual values: Fiscal year 2024: $1.92 million | Fiscal year 2023: $3.14 million | Fiscal year 2022: $4.68 million | Fiscal year 2021: $1.42 million | Fiscal year 2020: $463.3 thousand.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: